Welcome to our dedicated page for Veeco Instrs Del news (Ticker: VECO), a resource for investors and traders seeking the latest updates and insights on Veeco Instrs Del stock.
Veeco Instruments Inc. reports developments in semiconductor process equipment used in advanced device fabrication and packaging. The company designs, develops and manufactures laser annealing, ion beam, metal organic chemical vapor deposition (MOCVD), single-wafer etch and clean, lithography and related thin-film processing systems.
Recurring news includes customer equipment orders for Spector Ion Beam Deposition, Lumina MOCVD and WaferEtch Wet Processing systems, including applications in indium phosphide lasers, silicon photonics and optical transceivers for data-center communications. Updates also cover quarterly and annual financial results, management conference participation and other material corporate disclosures tied to orders, manufacturing demand and operating performance.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Veeco Instruments (NASDAQ: VECO) is set to release its Q1 2023 financial results on May 8, 2023, post-market closure. A conference call will begin at 5:00 PM ET to discuss the results, with access available via phone or a live webcast on Veeco's investor relations website.
Veeco specializes in manufacturing semiconductor process equipment, including laser annealing, ion beam, and chemical vapor deposition technologies. These innovations are vital for the production of advanced semiconductor devices. Their equipment focuses on optimizing performance and reducing costs.
Investors are advised that the release may contain forward-looking statements that are subject to various risks, as detailed in their annual and quarterly reports.
Summary not available.
Veeco Instruments Inc. (Nasdaq: VECO) reported strong financial results for the fourth quarter and fiscal year ended December 31, 2022. Revenues reached $153.8 million, slightly up from $153.0 million the previous year. GAAP net income soared to $128.9 million or $2.00 per diluted share, a significant increase compared to $8.2 million, or $0.15 per diluted share in Q4 2021. For the fiscal year, revenues totaled $646.1 million, up from $583.3 million. Despite a slight decrease in non-GAAP net income in Q4, the company remains optimistic for 2023, expecting revenues between $130 million and $150 million and focusing on R&D investment.